<Suppliers Price>

WAY-262611

Names

[ CAS No. ]:
1123231-07-1

[ Name ]:
WAY-262611

[Synonym ]:
1-{1-[4-(2-Naphthyl)-2-pyrimidinyl]-4-piperidinyl}methanamine
4-Piperidinemethanamine, 1-[4-(2-naphthalenyl)-2-pyrimidinyl]-
1-{1-[4-(2-Naphthyl)pyrimidin-2-yl]piperidin-4-yl}methanamine
WAY-262611

Biological Activity

[Description]:

WAY-262611 is a wingless β-Catenin agonist that increases bone formation rate with an EC50 of 0.63 μM in TCF-Luciferase assay.

[Related Catalog]:

Signaling Pathways >> Stem Cell/Wnt >> β-catenin
Research Areas >> Cancer

[Target]

EC50: 0.63 μM (β-Catenin)[1]


[In Vitro]

WAY-262611 has the most potent activity in the primary assay, low kinase inhibition potential, and high solubility[1].

[In Vivo]

WAY-262611 has excellent pharmacokinetic properties and shows a dose dependent increase in the trabecular bone formation rate in ovariectomized rats following oral administration. Calvariae from wt mice treated with WAY-262611 shows statistically increased BFR, while similarly treated KO animals are no different from control. This indicates that WAY-262611 is acting via the Wnt β-catenin pathway and most likely through inhibition of Dkk-1[1].

[Animal admin]

Rats: WAY-262611 is dissolved in DMSO and diluted with saline for iv (Rats). WAY-262611 is prepared in 0.5% methylcellulose/2% Tween-80 for po OVX rats14 are treated orally with 5 (po, vehicle=0.5% methylcellulose/2% Tween-80, qd, 28 days) at four doses. Trabecular bone formation rate (BFR) in the tibia is established in all dose groups at the end of the in-life portion of the study. A clear dose response and activity as low as 0.3 mg/kg/day are observed[1]. Mice: To confirm activity via the Wnt pathway, the calvariae of wild type (wt) and Dkk-1 knockout (KO) mice are treated with 5 once a day for 7 days (DMSO solution, sc injection). The KO animals are not expected to respond because of the inherent inability to inhibit a missing target protein, while wild type animals with fully expressed Dkk-1 are expected to show a pharmacological response [1].

[References]

[1]. Pelletier JC, et al. (1-(4-(Naphthalen-2-yl)pyrimidin-2-yl)piperidin-4-yl)methanamine: a wingless beta-catenin agonist that increases bone formation rate. J Med Chem. 2009 Nov 26;52(22):6962-5.


[Related Small Molecules]

XAV-939 | Salinomycin | Berberine chloride hydrate | KYA 1797K | FH535 | SKL2001 | LF3 | PNU 74654 | KY1220 | Pamidronic acid | Cardiogenol C (hydrochloride) | WIKI4 | Nefopam hydrochloride | Triptonide

Chemical & Physical Properties

[ Density]:
1.2±0.1 g/cm3

[ Boiling Point ]:
544.8±42.0 °C at 760 mmHg

[ Molecular Formula ]:
C20H22N4

[ Molecular Weight ]:
318.415

[ Flash Point ]:
283.3±27.9 °C

[ Exact Mass ]:
318.184448

[ PSA ]:
55.04000

[ LogP ]:
4.09

[ Vapour Pressure ]:
0.0±1.5 mmHg at 25°C

[ Index of Refraction ]:
1.638

[ Storage condition ]:
2-8℃


Related Compounds